Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 23Lung Neoplasms 12Prostatic Neoplasms 10Squamous Cell Carcinoma of Head and Neck 8Breast Neoplasms 5Stomach Neoplasms 4Prostatic Neoplasms, Castration-Resistant 4Neoplasms 4Neoplasm Metastasis 3Endometrial Neoplasms 3Carcinoma, Transitional Cell 3Carcinoma 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Oropharyngeal Neoplasms 2Nasopharyngeal Carcinoma 2Melanoma 2Lymphoid Interstitial Pneumonia 2Head and Neck Neoplasms 2HER2-positive Breast Cancer 2Esophageal Neoplasms 2Anatomic Stage I Breast Cancer AJCC v8 2Vaccinia 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urothelial Cancer 1Tongue Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Solid Tumors 1

Interventions

nilutamide 1luprolide acetate gel depot 1bicalutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Salicylic Acid 1Radiation 1Leuprolide 1Goserelin 1Flutamide 1Docetaxel 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stage I Prostate Adenocarcinoma AJCC v7 × Docetaxel × 30 days × Clear all
NCT03070886 2026-05-07

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

NRG Oncology

Phase 2/3 Completed
612 enrolled
Genitourinary

Stage I Prostate Adenocarcinoma AJCC v7

Data powered by HemOnc (CC BY 4.0) Colophon âš¡